Guergana Kirilova Savova, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Natural Language Processing | 58 | 2024 | 1134 | 7.640 |
Why?
|
Electronic Health Records | 45 | 2023 | 4761 | 3.270 |
Why?
|
Information Storage and Retrieval | 17 | 2023 | 821 | 2.400 |
Why?
|
Data Mining | 14 | 2019 | 551 | 1.820 |
Why?
|
Aneurysm, Ruptured | 14 | 2021 | 459 | 1.590 |
Why?
|
Intracranial Aneurysm | 18 | 2024 | 1276 | 1.520 |
Why?
|
Vocabulary, Controlled | 9 | 2014 | 167 | 1.200 |
Why?
|
Algorithms | 30 | 2021 | 13961 | 1.030 |
Why?
|
Semantics | 11 | 2019 | 599 | 0.990 |
Why?
|
Narration | 6 | 2013 | 219 | 0.940 |
Why?
|
Linguistics | 4 | 2013 | 106 | 0.910 |
Why?
|
Computer Systems | 3 | 2017 | 470 | 0.670 |
Why?
|
Disease | 2 | 2015 | 671 | 0.670 |
Why?
|
Medical Records Systems, Computerized | 6 | 2013 | 1190 | 0.630 |
Why?
|
Classification | 2 | 2009 | 127 | 0.620 |
Why?
|
APACHE | 1 | 2017 | 267 | 0.550 |
Why?
|
Artificial Intelligence | 10 | 2023 | 2551 | 0.520 |
Why?
|
Software | 6 | 2023 | 4415 | 0.500 |
Why?
|
Neoplasms | 11 | 2024 | 22032 | 0.490 |
Why?
|
Radiation Oncology | 1 | 2021 | 563 | 0.480 |
Why?
|
Medical Informatics | 5 | 2017 | 732 | 0.450 |
Why?
|
Subarachnoid Hemorrhage | 5 | 2019 | 1031 | 0.440 |
Why?
|
Anatomy | 1 | 2013 | 126 | 0.390 |
Why?
|
Pattern Recognition, Automated | 3 | 2013 | 994 | 0.370 |
Why?
|
Colitis, Ulcerative | 7 | 2019 | 1919 | 0.370 |
Why?
|
Anterior Cerebral Artery | 2 | 2021 | 50 | 0.370 |
Why?
|
Search Engine | 1 | 2011 | 140 | 0.350 |
Why?
|
Crohn Disease | 7 | 2019 | 2275 | 0.350 |
Why?
|
Basilar Artery | 2 | 2021 | 204 | 0.340 |
Why?
|
Arthritis, Rheumatoid | 3 | 2015 | 3755 | 0.320 |
Why?
|
Methotrexate | 1 | 2014 | 1719 | 0.300 |
Why?
|
Medical Oncology | 1 | 2019 | 2312 | 0.290 |
Why?
|
Pharmacogenetics | 1 | 2011 | 675 | 0.270 |
Why?
|
Language | 2 | 2024 | 1532 | 0.270 |
Why?
|
Phenotype | 10 | 2019 | 16534 | 0.270 |
Why?
|
Circle of Willis | 3 | 2021 | 79 | 0.270 |
Why?
|
Humans | 97 | 2024 | 758406 | 0.260 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2014 | 9273 | 0.250 |
Why?
|
Smoking | 3 | 2017 | 9051 | 0.240 |
Why?
|
Guidelines as Topic | 1 | 2011 | 1386 | 0.240 |
Why?
|
Cerebral Angiography | 5 | 2021 | 1275 | 0.230 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2011 | 1530 | 0.220 |
Why?
|
Pharmaceutical Preparations | 1 | 2011 | 1090 | 0.210 |
Why?
|
Esophagitis | 1 | 2023 | 163 | 0.200 |
Why?
|
Immunosuppressive Agents | 1 | 2014 | 4158 | 0.190 |
Why?
|
Breast Neoplasms | 3 | 2014 | 21017 | 0.190 |
Why?
|
Systematized Nomenclature of Medicine | 2 | 2014 | 34 | 0.190 |
Why?
|
Time | 2 | 2015 | 543 | 0.190 |
Why?
|
Medical Informatics Applications | 2 | 2013 | 178 | 0.180 |
Why?
|
Reference Standards | 3 | 2014 | 1003 | 0.180 |
Why?
|
Middle Cerebral Artery | 1 | 2021 | 275 | 0.180 |
Why?
|
Severity of Illness Index | 3 | 2013 | 15785 | 0.170 |
Why?
|
Current Procedural Terminology | 1 | 2020 | 90 | 0.170 |
Why?
|
Peripheral Arterial Disease | 1 | 2010 | 1246 | 0.160 |
Why?
|
Disabled Persons | 2 | 2007 | 1224 | 0.160 |
Why?
|
Health Facilities | 1 | 2023 | 578 | 0.160 |
Why?
|
Ecosystem | 1 | 2021 | 487 | 0.140 |
Why?
|
Heroin Dependence | 1 | 2017 | 172 | 0.140 |
Why?
|
Disease Progression | 2 | 2013 | 13468 | 0.140 |
Why?
|
International Normalized Ratio | 1 | 2018 | 382 | 0.140 |
Why?
|
Clinical Coding | 2 | 2015 | 180 | 0.130 |
Why?
|
Unified Medical Language System | 2 | 2014 | 89 | 0.130 |
Why?
|
Female | 40 | 2024 | 390323 | 0.130 |
Why?
|
Nursing Care | 2 | 2007 | 65 | 0.130 |
Why?
|
Knowledge Bases | 1 | 2016 | 97 | 0.130 |
Why?
|
Activities of Daily Living | 1 | 2005 | 2414 | 0.130 |
Why?
|
Aneurysm | 1 | 2018 | 336 | 0.120 |
Why?
|
Terminology as Topic | 5 | 2013 | 1533 | 0.120 |
Why?
|
Prostate | 1 | 2023 | 1791 | 0.120 |
Why?
|
Genetic Association Studies | 2 | 2017 | 2717 | 0.120 |
Why?
|
Reproducibility of Results | 6 | 2017 | 20055 | 0.120 |
Why?
|
Magnesium | 1 | 2018 | 809 | 0.120 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 2016 | 4342 | 0.120 |
Why?
|
Gastrointestinal Agents | 2 | 2016 | 508 | 0.110 |
Why?
|
High-Throughput Screening Assays | 1 | 2019 | 933 | 0.110 |
Why?
|
Medical Informatics Computing | 1 | 2013 | 24 | 0.110 |
Why?
|
Hypolipidemic Agents | 1 | 2018 | 609 | 0.110 |
Why?
|
Male | 34 | 2024 | 358747 | 0.110 |
Why?
|
Esophageal Neoplasms | 1 | 2023 | 1648 | 0.110 |
Why?
|
Ownership | 1 | 2015 | 339 | 0.110 |
Why?
|
Models, Theoretical | 3 | 2016 | 3561 | 0.100 |
Why?
|
Logistic Models | 8 | 2019 | 13276 | 0.100 |
Why?
|
Case-Control Studies | 9 | 2021 | 22029 | 0.100 |
Why?
|
Cholesterol, HDL | 1 | 2018 | 1808 | 0.100 |
Why?
|
Confidentiality | 2 | 2013 | 610 | 0.100 |
Why?
|
Anxiety Disorders | 2 | 2013 | 2714 | 0.100 |
Why?
|
Medical Records | 5 | 2020 | 1406 | 0.090 |
Why?
|
Nursing Records | 2 | 2008 | 30 | 0.090 |
Why?
|
Documentation | 2 | 2008 | 892 | 0.090 |
Why?
|
Health | 2 | 2005 | 398 | 0.090 |
Why?
|
Iron | 1 | 2019 | 1786 | 0.090 |
Why?
|
Decision Support Systems, Clinical | 2 | 2011 | 1162 | 0.090 |
Why?
|
Registries | 2 | 2023 | 8175 | 0.090 |
Why?
|
Middle Aged | 23 | 2024 | 219568 | 0.090 |
Why?
|
Depressive Disorder | 2 | 2013 | 3727 | 0.090 |
Why?
|
Warfarin | 1 | 2018 | 1482 | 0.090 |
Why?
|
Data Interpretation, Statistical | 2 | 2019 | 2690 | 0.090 |
Why?
|
Psychology | 1 | 2011 | 356 | 0.080 |
Why?
|
Information Systems | 1 | 2011 | 397 | 0.080 |
Why?
|
Methods | 1 | 2009 | 1074 | 0.080 |
Why?
|
Angiography, Digital Subtraction | 2 | 2021 | 335 | 0.080 |
Why?
|
Computational Biology | 2 | 2016 | 3502 | 0.080 |
Why?
|
Hypertension, Pulmonary | 1 | 2020 | 1564 | 0.080 |
Why?
|
Aged | 18 | 2024 | 168218 | 0.080 |
Why?
|
Radiology Information Systems | 2 | 2013 | 528 | 0.080 |
Why?
|
Quality Indicators, Health Care | 1 | 2018 | 1797 | 0.080 |
Why?
|
Risk Factors | 14 | 2024 | 73809 | 0.080 |
Why?
|
Nursing Diagnosis | 2 | 2008 | 16 | 0.070 |
Why?
|
Biomedical Research | 5 | 2024 | 3418 | 0.070 |
Why?
|
Aromatase Inhibitors | 1 | 2011 | 511 | 0.070 |
Why?
|
Peripheral Vascular Diseases | 1 | 2010 | 488 | 0.070 |
Why?
|
Sensitivity and Specificity | 3 | 2011 | 14641 | 0.070 |
Why?
|
Inflammatory Bowel Diseases | 2 | 2019 | 2420 | 0.070 |
Why?
|
Tamoxifen | 1 | 2011 | 963 | 0.070 |
Why?
|
Information Services | 1 | 2008 | 235 | 0.070 |
Why?
|
Aspirin | 1 | 2018 | 3131 | 0.070 |
Why?
|
Child | 5 | 2023 | 79818 | 0.070 |
Why?
|
Smoking Cessation | 1 | 2017 | 2055 | 0.060 |
Why?
|
ROC Curve | 1 | 2013 | 3563 | 0.060 |
Why?
|
Age Factors | 3 | 2021 | 18358 | 0.060 |
Why?
|
Cohort Studies | 6 | 2020 | 41256 | 0.060 |
Why?
|
Multivariate Analysis | 4 | 2020 | 12096 | 0.060 |
Why?
|
Calcium | 1 | 2018 | 5721 | 0.060 |
Why?
|
Hypoglycemic Agents | 1 | 2017 | 3069 | 0.060 |
Why?
|
Adult | 18 | 2024 | 219935 | 0.060 |
Why?
|
Alcohol Drinking | 1 | 2017 | 4018 | 0.060 |
Why?
|
Patient Readmission | 1 | 2018 | 3261 | 0.060 |
Why?
|
Information Dissemination | 1 | 2012 | 1129 | 0.060 |
Why?
|
Nursing | 1 | 2003 | 34 | 0.060 |
Why?
|
Minnesota | 3 | 2010 | 338 | 0.060 |
Why?
|
Vitamin D Deficiency | 1 | 2013 | 1377 | 0.060 |
Why?
|
Antirheumatic Agents | 1 | 2013 | 1368 | 0.060 |
Why?
|
Rheumatic Diseases | 1 | 2010 | 639 | 0.050 |
Why?
|
Hospitalization | 2 | 2013 | 10652 | 0.050 |
Why?
|
Imaging, Three-Dimensional | 3 | 2021 | 4048 | 0.050 |
Why?
|
Anticoagulants | 1 | 2018 | 4777 | 0.050 |
Why?
|
Silver | 1 | 2023 | 116 | 0.050 |
Why?
|
Child, Preschool | 4 | 2020 | 42062 | 0.050 |
Why?
|
Computer Simulation | 2 | 2013 | 6201 | 0.050 |
Why?
|
Databases, Factual | 4 | 2015 | 7980 | 0.050 |
Why?
|
Genomics | 3 | 2016 | 5790 | 0.050 |
Why?
|
Odds Ratio | 3 | 2018 | 9650 | 0.050 |
Why?
|
Informatics | 1 | 2021 | 73 | 0.050 |
Why?
|
Workload | 1 | 2007 | 847 | 0.050 |
Why?
|
Learning | 1 | 2010 | 1739 | 0.050 |
Why?
|
International Classification of Diseases | 2 | 2016 | 892 | 0.050 |
Why?
|
Pathology, Surgical | 2 | 2013 | 151 | 0.050 |
Why?
|
Decision Support Techniques | 1 | 2011 | 1996 | 0.050 |
Why?
|
Propensity Score | 2 | 2018 | 1907 | 0.040 |
Why?
|
Sample Size | 1 | 2023 | 838 | 0.040 |
Why?
|
Disability Evaluation | 2 | 2005 | 1825 | 0.040 |
Why?
|
Retrospective Studies | 7 | 2024 | 80168 | 0.040 |
Why?
|
Vitamin D | 1 | 2013 | 3283 | 0.040 |
Why?
|
Diabetes Mellitus | 2 | 2015 | 5816 | 0.040 |
Why?
|
Aortic Aneurysm | 1 | 2024 | 648 | 0.040 |
Why?
|
Self Care | 1 | 2005 | 794 | 0.040 |
Why?
|
Technology | 1 | 2021 | 292 | 0.040 |
Why?
|
Psychiatry | 1 | 2011 | 1689 | 0.040 |
Why?
|
Data Collection | 1 | 2008 | 3322 | 0.040 |
Why?
|
Liver | 1 | 2014 | 7502 | 0.040 |
Why?
|
Telemedicine | 1 | 2016 | 3018 | 0.040 |
Why?
|
Colestipol | 1 | 2018 | 11 | 0.040 |
Why?
|
Multiple Sclerosis | 1 | 2013 | 3204 | 0.040 |
Why?
|
Cholestyramine Resin | 1 | 2018 | 25 | 0.040 |
Why?
|
Skilled Nursing Facilities | 1 | 2003 | 394 | 0.040 |
Why?
|
Fibric Acids | 1 | 2018 | 27 | 0.040 |
Why?
|
Risk | 2 | 2020 | 9599 | 0.040 |
Why?
|
Research Design | 2 | 2011 | 6157 | 0.040 |
Why?
|
Social Environment | 1 | 2023 | 1023 | 0.040 |
Why?
|
Rupture, Spontaneous | 1 | 2018 | 353 | 0.040 |
Why?
|
Models, Biological | 1 | 2013 | 9460 | 0.040 |
Why?
|
Italy | 1 | 2019 | 839 | 0.040 |
Why?
|
Chromosomes, Human, Pair 22 | 1 | 2017 | 346 | 0.030 |
Why?
|
Statistics as Topic | 1 | 2003 | 2359 | 0.030 |
Why?
|
Genotype | 1 | 2011 | 12945 | 0.030 |
Why?
|
Ferritins | 1 | 2019 | 597 | 0.030 |
Why?
|
Coronary Artery Disease | 1 | 2015 | 6362 | 0.030 |
Why?
|
Critical Care | 1 | 2008 | 2692 | 0.030 |
Why?
|
Organ Size | 1 | 2020 | 2252 | 0.030 |
Why?
|
Physicians | 1 | 2013 | 4580 | 0.030 |
Why?
|
Oligonucleotides | 1 | 2018 | 582 | 0.030 |
Why?
|
Pilot Projects | 2 | 2006 | 8553 | 0.030 |
Why?
|
Risk Adjustment | 1 | 2018 | 600 | 0.030 |
Why?
|
United States | 5 | 2019 | 72136 | 0.030 |
Why?
|
Chromosome Disorders | 1 | 2017 | 499 | 0.030 |
Why?
|
Comorbidity | 3 | 2016 | 10495 | 0.030 |
Why?
|
Prognosis | 4 | 2016 | 29557 | 0.030 |
Why?
|
Image Processing, Computer-Assisted | 2 | 2021 | 8945 | 0.030 |
Why?
|
Research | 1 | 2021 | 1976 | 0.030 |
Why?
|
Follow-Up Studies | 4 | 2016 | 39059 | 0.030 |
Why?
|
Benzimidazoles | 1 | 2018 | 855 | 0.030 |
Why?
|
Chromosome Deletion | 1 | 2017 | 1387 | 0.030 |
Why?
|
Area Under Curve | 1 | 2016 | 1632 | 0.030 |
Why?
|
Intensive Care Units | 1 | 2006 | 3732 | 0.030 |
Why?
|
Pennsylvania | 1 | 2013 | 614 | 0.020 |
Why?
|
Computer Security | 1 | 2013 | 260 | 0.020 |
Why?
|
Early Diagnosis | 1 | 2016 | 1177 | 0.020 |
Why?
|
Polycystic Ovary Syndrome | 1 | 2015 | 376 | 0.020 |
Why?
|
Genome-Wide Association Study | 1 | 2010 | 12604 | 0.020 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2011 | 11709 | 0.020 |
Why?
|
Database Management Systems | 1 | 2012 | 257 | 0.020 |
Why?
|
Databases, Genetic | 1 | 2017 | 1737 | 0.020 |
Why?
|
Hyperlipidemias | 1 | 2015 | 772 | 0.020 |
Why?
|
Postoperative Complications | 1 | 2013 | 15637 | 0.020 |
Why?
|
Regression Analysis | 1 | 2020 | 6354 | 0.020 |
Why?
|
Prospective Studies | 3 | 2019 | 54137 | 0.020 |
Why?
|
Technology Assessment, Biomedical | 1 | 2012 | 306 | 0.020 |
Why?
|
National Cancer Institute (U.S.) | 1 | 2010 | 296 | 0.020 |
Why?
|
Interdisciplinary Communication | 1 | 2015 | 931 | 0.020 |
Why?
|
Nursing Evaluation Research | 1 | 2008 | 26 | 0.020 |
Why?
|
Medical Record Linkage | 1 | 2010 | 287 | 0.020 |
Why?
|
Models, Nursing | 1 | 2008 | 45 | 0.020 |
Why?
|
Cholesterol, LDL | 1 | 2018 | 2374 | 0.020 |
Why?
|
Numerical Analysis, Computer-Assisted | 1 | 2008 | 119 | 0.020 |
Why?
|
Nursing Assessment | 1 | 2008 | 106 | 0.020 |
Why?
|
Software Design | 1 | 2008 | 171 | 0.020 |
Why?
|
Nursing Process | 1 | 2007 | 16 | 0.020 |
Why?
|
Forms and Records Control | 1 | 2008 | 158 | 0.020 |
Why?
|
Nursing Research | 1 | 2008 | 80 | 0.020 |
Why?
|
Insurance, Health | 1 | 2020 | 2495 | 0.020 |
Why?
|
Epidemiologic Studies | 1 | 2010 | 670 | 0.020 |
Why?
|
Decision Trees | 1 | 2008 | 504 | 0.020 |
Why?
|
Bayes Theorem | 1 | 2014 | 2322 | 0.020 |
Why?
|
Anti-Inflammatory Agents | 1 | 2016 | 1793 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2018 | 10748 | 0.020 |
Why?
|
Observer Variation | 1 | 2012 | 2600 | 0.020 |
Why?
|
Heart Diseases | 1 | 2019 | 2782 | 0.020 |
Why?
|
Recurrence | 1 | 2018 | 8426 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2016 | 6293 | 0.020 |
Why?
|
Nursing Informatics | 1 | 2006 | 46 | 0.020 |
Why?
|
Socioeconomic Factors | 1 | 2018 | 7818 | 0.010 |
Why?
|
Nerve Tissue Proteins | 1 | 2017 | 4406 | 0.010 |
Why?
|
Cooperative Behavior | 1 | 2011 | 1501 | 0.010 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2018 | 3227 | 0.010 |
Why?
|
Hospitals, Pediatric | 1 | 2012 | 1854 | 0.010 |
Why?
|
Academic Medical Centers | 1 | 2013 | 2751 | 0.010 |
Why?
|
Time Factors | 2 | 2018 | 39872 | 0.010 |
Why?
|
User-Computer Interface | 1 | 2008 | 1397 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2009 | 36284 | 0.010 |
Why?
|
Quality of Life | 1 | 2023 | 13285 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2024 | 58683 | 0.010 |
Why?
|
Sex Factors | 1 | 2013 | 10504 | 0.010 |
Why?
|
Internet | 1 | 2010 | 3082 | 0.010 |
Why?
|
Population Surveillance | 1 | 2008 | 2606 | 0.010 |
Why?
|
Risk Assessment | 1 | 2018 | 23884 | 0.010 |
Why?
|
Radiology | 1 | 2010 | 2102 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2007 | 5199 | 0.010 |
Why?
|
Infant | 1 | 2016 | 36055 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2012 | 25956 | 0.010 |
Why?
|
Adolescent | 1 | 2018 | 87892 | 0.010 |
Why?
|
Health Status | 1 | 2003 | 4071 | 0.010 |
Why?
|
Young Adult | 1 | 2016 | 58808 | 0.010 |
Why?
|
Quality of Health Care | 1 | 2003 | 4317 | 0.000 |
Why?
|